Note: Ingredients listed on restricted chemical lists
EC/CAS
215-267-0/1317-36-8
Name of the chemical
Lead monoxide (lead oxide)
Concentration
<= 100 %
General Information
Version
6.21
Revision date
2025-03-12
Product name
Lead(II) oxide for analysis EMSURE
CAS No.
1317-36-8
REACH No
01-2119531110-62-XXXX
1.2.1 Relevant identified uses
Reagent for analysis
Emergency telephone
+(44)-870-8200418, +(353)-19014670, 001-803-017-9114
Icons in SDS
Company Information
company name
Merck KGaA
e-mail address of the competent person responsible for the Safety Data Sheet
TechnicalService@merckgroup.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H302+H332, H332, H351, H360Df, H362, H372, H400, H410
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Acute toxicity, (Category 4) H302: Harmful if swallowed. Acute toxicity, (Category 4) H332 Harmful if inhaled. Carcinogenicity, (Category 2) H351 Suspected of causing cancer. Reproductive toxicity, (Category H360Df May damage the unborn child 1A) Suspected of damaging fertility. Effects on or via lactation H362 May cause harm to breast-fed children. Specific target organ toxicity - H372 Causes damage to organs through repeated exposure, (Category 1), prolonged or repeated exposure Central nervous system, Kidney, Blood Short-term (acute) aquatic H400: Very toxic to aquatic life. hazard, (Category 1) Long-term (chronic) aquatic H410: Very toxic to aquatic life with long hazard, (Category 1) lasting effects.
2.2 Label elements
Labelling
Signal word
Danger Danger
Hazard statements
H302 + H332 Harmful if swallowed or if inhaled. H351 Suspected of causing cancer. H360Df May damage the unborn child. Suspected of damaging fertility. H362 May cause harm to breast-fed children. H372 Causes damage to organs (Central nervous system, Kidney, Blood) through prolonged or repeated exposure. H410 Very toxic to aquatic life with long lasting effects. Restricted to professional users. "As from 24 August 2023 adequate training is required before industrial or professional use." Reduced Labeling (<= 125 ml) H351 Suspected of causing cancer. H362 May cause harm to breast-fed children. H372 Causes damage to organs through prolonged or repeated exposure. H360Df May damage the unborn child. Suspected of damaging fertility.
Precautionary statements
P260 Do not breathe dust. P263 Avoid contact during pregnancy and while nursing. P273 Avoid release to the environment. P301 + P312 IF SWALLOWED: Call a POISON CENTER/ doctor if you feel unwell. P304 + P340 + P312 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/ doctor if you feel unwell. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P260 Do not breathe dust. P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Supplemental label elements
none none
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.